相关实验视频

Updated: Jan 7, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

针对性疗法的作用在形血细胞状树突细胞瘤中

Roberta S Azevedo¹, Zohra Nooruddin², Sumeet Bhatia³

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Expert opinion on biological therapy

|December 25, 2025

概括

囊性血细胞状树突细胞瘤 (BPDCN) 治疗已经通过像tagraxofusp.com这样的向疗法取得了进展. 针对CD123和其他途径的新策略为改善这种罕见癌症的结果提供了希望.

科学领域:

血液学血液学血液学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

囊性血细胞状树突细胞瘤 (BPDCN) 是一种极为罕见的血液性恶性瘤.
从历史上看,BPDCN缺乏标准化疗,导致患者的治疗结果不佳.
许多患者无法接受强化治疗,如化疗,临床试验或干细胞移植.

研究的目的:

审查目前针对BPDCN的向治疗方法.
突出最近和新兴的治疗策略.
讨论临床实施中的挑战,包括不良事件,成本和可访问性.

主要方法:

在BPDCN中针对性治疗的文献综述.
最近临床进展和研究方法的总结.
讨论治疗实施的障碍.

主要成果:

抗CD123剂Tagraxofusp在BPDCN治疗中开创了一个新时代,具有高响应率.
开发额外的CD123向疗法,包括抗体-药物合物和细胞疗法.
研究方法包括BCL2抑制剂,蛋白酶体抑制剂和向CD38,CD303和BET的疗法.

结论:

向疗法,特别是抗CD123药物,已经显著改善了BPDCN治疗模式.
新兴的策略有望进一步提高患者的治疗结果.
解决不良事件,成本和可访问性对于广泛的临床益处至关重要.

关键词:

BPDCN BPDCN 在线播放 CD123 有针对性的代理商.新的目标,新的目标.有针对性的治疗.维尼托克拉克斯 (Venetoclax) 是一个

更多相关视频

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...